If you're taking a GLP-1 medication for weight loss, you may have questions about managing side effects and whether to take nutritional supplements to support your health. As a pharmacist, I' ...

The GLP‑1 beverage market is accelerating fast, with brands innovating in hydration, protein, fibre and collagen to meet soaring consumer demand. Discover the growth forecasts, key ingredients, and ...

With the help of four expert nutritionists, the Good Housekeeping Institute tried and tested the best vegan protein powder on the market. Shop now.

Some less common but serious side effects of gabapentin include suicidal thoughts, allergic reactions, and serious breathing ...

Echinacea is generally safe for most people to consume in the short term. Learn about potentially serious side effects of echinacea and who should avoid it.

A team of University of Kentucky researchers has uncovered a surprising clue in the battle against Alzheimer's disease that could help doctors predict, and ultimately prevent, a common side effect of ...

Side effects of Ozempic seem to be similar in males and females. Some evidence suggests that females may be more likely to have side effects from GLP-1 receptor agonists, but this hasn’t been ...

As part of an investigation that dates back to 2023, the FDA has identified over two dozen products featuring the plant.

Common side effects of Auvelity (dextromethorphan/bupropion) include dizziness, headache, diarrhea, and dry mouth. Serious side effects are uncommon, but possible ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

More and more Americans are turning to side hustles for additional income. A survey by MyPerfectResume in January found that 72 percent of workers in the U.S. currently rely on secondary income—and ...

The half-hour series follows Marshall and Frances, two former high school lab partners who share a secret: Marshall has discovered the world’s greatest medicine, a mushroom that can heal almost ...